Foundation for Interventional and Therapeutic Endoscopy
Nonprofit profile at a glance
- EIN
- 881643047
- IRS 990-EZ coverage
- 2023–2024
- Forms available
- Form 990-EZ 2024, Form 990-N 2022
- Location
- New Brunswick, NJ, USA
- Rating
- 59
- Verdict
- MIXED
- Rating confidence
- Moderate
- Sector
- Digestive Diseases, Disorders
Reported finances
- Revenue
- $90,024
- Expenses
- $49,562
- Assets
- $81,727
Source: IRS Form 990-EZ. Selected filing: tax year 2024. Amounts in USD.
Leadership & pay
8 people listed
Executive titles in this filing
- Michel Kahaleh (CEO)
- David Loren (President)
- David Diehl (Vice President)
People named in this filing
- Michel Kahaleh (CEO)
- Monica Gaidhane (CFO Interim CIO and CMO)
- David Loren (President)
Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.
Source: IRS Form 990-EZ. Selected filing: tax year 2024. Names and roles reflect this filing, not necessarily current officeholders.
Overview
Mission
FITE is the first and only organization that is exclusively dedicated to interventional and therapeutic endoscopists in the US. FITE is also a 501c3 designated non-profit organization. The foundation will enhance & promote the expansion of the field of advanced therapeutic endoscopy thereby increasing access to specialized endoscopic procedures while reducing cost and morbidity for patients in a manner that promotes uniform quality training and credentialing in order to optimize healthcare value and outcomes for patients. We recognize that therapeutic endoscopy will play a greater role in the care of digestive diseases cancers and obesity in the future. The foundation will function to develop awareness research and pathways for complex procedures. This includes: standardization of training creation of criteria for uniform credentialing and privileging advocating for reimbursement codes for niche interventions research collaborations and support dedicated to interventio
What it reported doing in 2024
Exhibit of FITE to advocate and spread awareness to 4000 and more gastroenterologists regarding the educational content we provide. Exhibit was held at Digestive Disease Week 2024
Operating model
- Revenue model
- Donor-supported. 100% of the money available for current operations came from contributions and gifts.
- Distribution model
- Direct operator. The filing allocates 93% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.
The verdict
MIXED - The filed numbers largely add up and revenue comfortably covers expenses. A relatively small share of available resources goes toward mission work and a relatively small share of total spending goes to programs.
Rating breakdown
- Financial Efficiency: 30
- Transparency & Controls: 100
- Sustainability: 66
- Growth: 20
Detailed rating inputs
Financial Efficiency
- Mission deployment rate: 23%; rating input score 23
- Program expense ratio: 41.9%; rating input score 42
Transparency & Controls
- Consistency checks: 100%; rating input score 100; 52nd percentile among comparable filings
- Major donor itemization: Yes; rating input score 100
Sustainability
- Operating margin: 44.9%; rating input score 89; 89th percentile among comparable filings
- Total-asset coverage ratio: 1.65; rating input score 60; 60th percentile among comparable filings
- Liabilities to assets ratio: Limited
- Officer compensation ratio: 0%; rating input score 56; 56th percentile among comparable filings
Growth
- Program expense growth: -60% per year; rating input score 0; 7th percentile among comparable filings
- Revenue growth: -1.6% per year; rating input score 0; 45th percentile among comparable filings
- Asset growth: 65.8% per year; rating input score 100; 97th percentile among comparable filings
Details
- Where the money goes: 23% of revenue deployed · 41.9% of spending went to programs
- Governance: Filed governance answers
- Accomplishments: 3 filed program accomplishments · $21K in reported program spending
- Leadership: top reported pay $0 · 8 people listed
- Consistency: 8 of 8 current checks pass
- Schedules: 3 filed schedules
- Filing history: 2 filing years from 2023 to 2024
- Contacts: How to reach this organization
- Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
- People: Everyone the filings name, and which of them the filings identify by more than a name.
Key Signals
Signals prioritize questions for review. They are not findings of misconduct.
- High — Financial Efficiency: Mission deployment rate scored 23/100.
- Moderate — Financial Efficiency: Program expense ratio scored 42/100.
- High — Growth: Program expense growth scored 0/100.
- High — Growth: Revenue growth scored 0/100.
- Review — Sustainability: Officer compensation ratio scored 56/100.